Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuiping Gao
Observed names:
Shui-Ping Gao,
Shui-ping Gao,
Shui‐Ping Gao,
Shui‑Ping Gao
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Tongji University,
Shanghai Medical College of Fudan University,
Henan University of Science and Technology,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai East Hospital
show all 6
ORCID:
0000-0002-9895-1650
Observed ORCID:
0000-0002-9895-1650
OpenAlex ID:
A5068534357
Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
2017
·
Meng-Ting Chen
, He-Fen Sun
, et al.
·
Scientific Reports
·
247
PDF
Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism
2015
·
Liang-Dong Li
, He-Fen Sun
, et al.
·
PLoS ONE
·
93
PDF
Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours
2023
·
Jian Zhang
, Rujiao Liu
, et al.
·
npj Breast Cancer
·
60
PDF
SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
2019
·
Peng-Fei Zhang
, Jing Wu
, et al.
·
Aging
·
53
PDF
Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling
2015
·
Hong-Lin Jiang
, He-Fen Sun
, et al.
·
Oncotarget
·
52
PDF
Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer
2015
·
Shui-Ping Gao
, He-Fen Sun
, et al.
·
Oncotarget
·
47
PDF
Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer
2015
·
Shui-Ping Gao
, He-Fen Sun
, et al.
·
Tumor Biology
·
42
Downregulation of FOXP2 promotes breast cancer migration and invasion through TGFβ/SMAD signaling pathway
2018
·
Meng‑Ting Chen
, He‑Fen Sun
, et al.
·
Oncology Letters
·
35
PDF
Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene
2013
·
Qiaoqiao Wang
, Jiyu Li
, et al.
·
Acta Biochimica et Biophysica Sinica
·
35
Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population‐based study
2018
·
Yang Zhao
, He‐Fen Sun
, et al.
·
Cancer Medicine
·
34
PDF
UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter.
2017
·
Shui-Ping Gao
, He-Fen Sun
, et al.
·
PubMed
·
31
Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study
2017
·
He-Fen Sun
, Yang Zhao
, et al.
·
Oncotarget
·
30
PDF
Phase I study of A166 in patients with HER2-expressing locally advanced or metastatic solid tumors.
2021
·
Xichun Hu
, Jian Zhang
, et al.
·
Journal of Clinical Oncology
·
25
9MW2821, a nectin-4 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1/2a study.
2024
·
Jian Zhang
, Rujiao Liu
, et al.
·
Journal of Clinical Oncology
·
24
High expression of COX5B is associated with poor prognosis in breast cancer
2017
·
Shui-Ping Gao
, He-Fen Sun
, et al.
·
Future Oncology
·
20
Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors
2021
·
Rujiao Liu
, Wenhua Li
, et al.
·
Therapeutic Advances in Medical Oncology
·
16
PDF
Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors.
2024
·
Wungki Park
, Jian Zhang
, et al.
·
Journal of Clinical Oncology
·
14
Cancer‐Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities
2026
·
Rujiao Liu
, Lili Su
, et al.
·
Advanced Science
·
13
A phase 1, first-in-human, open-label, dose escalation and dose expansion study of TST005 in patients with locally advanced or metastatic solid tumors.
2023
·
Anthony W. Tolcher
, Xiaohua Wu
, et al.
·
Journal of Clinical Oncology
·
10
Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer
2018
·
Wenyan Fu
, Hefen Sun
, et al.
·
Oncotarget
·
8
PDF
IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: A phase I dose-escalation study.
2024
·
Rujiao Liu
, Xichun Hu
, et al.
·
Journal of Clinical Oncology
·
7
Updated results and biomarker analyses from the phase I trial of A166 in patients with HER2-expressing locally advanced or metastatic solid tumors.
2022
·
Xichun Hu
, Jian Zhang
, et al.
·
Journal of Clinical Oncology
·
7
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma
2024
·
Miaoyan Wei
, Rujiao Liu
, et al.
·
BMC Medicine
·
6
PDF
BPI-16350, a novel promising CDK4/6 inhibitor for HR+/HER2- metastatic breast cancer (MBC): Results from a phase I study.
2023
·
Jian Zhang
, Rujiao Liu
, et al.
·
Journal of Clinical Oncology
·
6
Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR ‐498 to promote proliferation and invasion of gastric cancer
2023
·
Rujiao Liu
, Xiaotian Han
, et al.
·
Journal of Clinical Laboratory Analysis
·
6
Show more works
View as search
Works count:
44
Citation count:
942
H-index:
16
I10-index:
19
Year
Topic
Type